Back to Shop
SS-31
Popular

SS-31 10mg

Longevity

$149

4.0 (24 reviews)

Szeto-Schiller peptide that targets the inner mitochondrial membrane to reduce oxidative stress, restore mitochondrial function, and support cellular energy production.

Available in 10mg vial, lyophilized powder
Mitochondria-targeted antioxidant peptide
Third-party tested for purity and potency
Requires reconstitution with bacteriostatic water
1
Third-party tested

Overview

SS-31 (elamipretide) is a cell-permeable tetrapeptide that selectively concentrates in the inner mitochondrial membrane with 1,000-fold higher uptake than the cytoplasm. It binds to cardiolipin, a phospholipid critical for cristae structure and electron transport chain efficiency. Clinical trials have demonstrated improvements in heart failure, age-related muscle decline, and mitochondrial disease.

Lab Results — 10mg

Every batch is independently tested. Results below are from the Certificate of Analysis for the 10mg batch.

Test
Result
Status
Identity (LCMS)
Confirmed SS-31
Pass
Purity (HPLC)
99.789%
Pass
Net Peptide Content
11.97 mg
Pass
Appearance
White Lyophilized Powder
Pass
Endotoxin
Pass (Replicate 1 & 2)
Pass
Lot
ss10429
Pass

Certificate of Analysis

SS-31 10mg Certificate of Analysis

Scientific Details

Molecular Formula

C₃₂H₄₈N₈O₆

Molecular Weight

736.8 g/mol

Form

Lyophilized tetrapeptide powder

Solubility

Freely soluble in water

Dosage Range

0.1–0.25 mg/kg daily (research context)

Plasma Half-Life

~2–3 hours

Bioavailability

~85% subcutaneous

Resources

Key peer-reviewed studies supporting the efficacy and safety of this compound.

SS-31 reverses mitochondrial dysfunction and rescues diastolic function in heart failure

Chatfield K.C. et al.JACC: Basic to Translational Science (2019)

Key FindingSS-31 restored mitochondrial cristae morphology and improved cardiac energetics in a large animal model of heart failure with preserved ejection fraction.

Elamipretide improves mitochondrial function in aged skeletal muscle

Siegel M.P. et al.Aging Cell (2013)

Key FindingSS-31 treatment in aged mice improved mitochondrial ATP production, reduced ROS, and enhanced exercise capacity to levels approaching young animals.

Mitochondria-targeted peptide accelerates ATP recovery and reduces ROS generation

Szeto H.H.Pharmacology & Experimental Therapeutics (2008)

Key FindingSS-31 concentrated 1,000-fold in the inner mitochondrial membrane and reduced oxidative damage by over 70% in ischemia-reperfusion injury models.